CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $17,607,000 | +53.5% | 213,674 | +74.4% | 0.30% | +57.9% |
| Q2 2017 | $11,473,000 | +222.8% | 122,532 | +119.5% | 0.19% | +280.0% |
| Q1 2017 | $3,554,000 | +1458.8% | 55,819 | +780.8% | 0.05% | +2400.0% |
| Q3 2016 | $228,000 | -83.4% | 6,337 | -74.1% | 0.00% | -80.0% |
| Q4 2014 | $1,370,000 | -84.1% | 24,461 | -87.1% | 0.01% | -83.9% |
| Q3 2014 | $8,634,000 | +240.2% | 190,346 | +210.6% | 0.06% | +264.7% |
| Q2 2014 | $2,538,000 | +227.9% | 61,278 | +448.6% | 0.02% | +240.0% |
| Q1 2014 | $774,000 | – | 11,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |